As part of an ongoing webinar series, this live session took place on Tuesday, June 27th, 2017.
Under the Trump administration, the U.S. healthcare system is facing another major overhaul. Few sectors will see greater impact than health insurance exchanges, arguably the most visible piece of the Affordable Care Act. Insurers have struggled with exchange business due to high claims and problems with federal risk adjustment mechanisms. Younger people have not signed up in the numbers needed to balance the older, sicker enrollees who migrated from risk pool coverage to the exchanges. Already, some insurers have abandoned the marketplace, and the future of exchanges are very much in doubt.
Regardless of what form Republican-led reform ultimately takes, it will usher in significant changes for exchanges that will affect pharmaceutical companies and medical device makers. Exchanges could be phased out, and the individual market could revert to its previous condition. New “age bands” could lead to higher premiums for older enrollees, and account-based high-deductible plans are likely to expand. In the face of all this uncertainty, insurers will be unveiling their 2018 plans and strategies in mid-June.
The webinar will explore:
- How has the level of market competition changed since the launch of exchanges in 2014?
- What new developments are in store for the exchanges in 2018 and what does this mean for industry?
- What do Republican healthcare reforms mean for the future of exchanges?
- Which proposals championed by Republicans stand to have the greatest impact on your business?
What will be the impact of consolidation and other trends have on U.S. healthcare markets?
Presented by Mark Cherry, Bill Melville, Paula Wade, Roy Moore and Zaid Siddiqui